Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,211 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04227795 | AI-assisted Detection of Missed Colonic Polyps | completed | N/A | 52 | The University of Hong KongOTHER | 1 | Mar 4, 2020 | clinicaltrials |
| NCT03817489 | Mindfulness Meditation and Qigong for Colorectal Cancer Survivors | unknown | N/A | 189 | The University of Hong KongOTHER | 1 | Jan 30, 2020 | clinicaltrials |
| NCT04232748 |
| Change in Body Weight During Treatment of Advanced Colorectal Cancer |
| unknown |
| — |
| 264 |
| Tuen Mun HospitalOTHER_GOV |
| 1 |
| Jan 18, 2020 |
| clinicaltrials |
| NCT02031458 | A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer(BIRCH) | completed | Phase 2 | 667 | Hoffmann-La RocheINDUSTRY | 19 | Jan 6, 2020 | clinicaltrials |
| NCT00567190 | A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer(CLEOPATRA) | completed | Phase 3 | 808 | Genentech, Inc.INDUSTRY | 26 | Dec 13, 2019 | clinicaltrials |
| NCT02788279 | A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370) | completed | Phase 3 | 363 | Hoffmann-La RocheINDUSTRY | 11 | Dec 11, 2019 | clinicaltrials |
| NCT00908752 | Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC(BRISK TA) | completed | Phase 3 | 734 | Bristol-Myers SquibbINDUSTRY | 13 | Dec 2, 2019 | clinicaltrials |
| NCT02867371 | Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2(EAST2) | completed | N/A | 166 | Broncus Medical IncINDUSTRY | 4 | Nov 1, 2019 | clinicaltrials |
| NCT03979690 | Feasibility Study of a Novel Single Use Robotic Colonoscopy System | completed | N/A | 20 | Bio-Medical Engineering (HK) LimitedINDUSTRY | 1 | Oct 30, 2019 | clinicaltrials |
| NCT02108366 | Treatment of Severe Influenza A Infection | completed | Phase 3 | 107 | The University of Hong KongOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT00825955 | Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment(BRISK PS) | completed | Phase 3 | 587 | Bristol-Myers SquibbINDUSTRY | 19 | Oct 9, 2019 | clinicaltrials |
| NCT04120896 | Karate or Kung Fu? | unknown | N/A | 52 | The University of Hong KongOTHER | 1 | Oct 9, 2019 | clinicaltrials |
| NCT03830996 | Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal Carcinoma | unknown | — | 100 | The University of Hong KongOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT04108871 | Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men | unknown | N/A | 180 | The University of Hong KongOTHER | 1 | Sep 30, 2019 | clinicaltrials |
| NCT01599754 | Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients(ATLAS) | terminated | Phase 3 | 724 | SFJ Pharma Ltd. IIINDUSTRY | 9 | Sep 20, 2019 | clinicaltrials |
| NCT03217773 | ESD Versus TAMIS for Early Rectal Neoplasms | unknown | N/A | 114 | Chinese University of Hong KongOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT01837381 | Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC) | completed | N/A | 200 | Chinese University of Hong KongOTHER | 1 | Sep 3, 2019 | clinicaltrials |
| NCT01817205 | Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma | terminated | N/A | 8 | Chinese University of Hong KongOTHER | 1 | Aug 30, 2019 | clinicaltrials |
| NCT01834703 | Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine Fibroids | terminated | N/A | 85 | Chinese University of Hong KongOTHER | 1 | Aug 30, 2019 | clinicaltrials |
| NCT01877083 | Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung | completed | Phase 2 | 25 | Eisai Inc.INDUSTRY | 5 | Aug 13, 2019 | clinicaltrials |
| NCT01953913 | Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation | completed | Phase 3 | 542 | Boehringer IngelheimINDUSTRY | 5 | Aug 12, 2019 | clinicaltrials |
| NCT01055496 | Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma | completed | Phase 1 | 103 | PfizerINDUSTRY | 9 | Aug 2, 2019 | clinicaltrials |
| NCT01646125 | An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations | terminated | Phase 2 | 59 | Novartis PharmaceuticalsINDUSTRY | 12 | Jul 24, 2019 | clinicaltrials |
| NCT03623152 | Colorectal Neoplasia and Microbiota: Does Left Equal Right? | unknown | — | 160 | Chinese University of Hong KongOTHER | 1 | Jul 24, 2019 | clinicaltrials |
| NCT04030637 | The Diagnostic Accuracy of Using Faecal-DNA Test (COLOSAFE) for Colorectal Cancer Screening | unknown | — | 400 | Chinese University of Hong KongOTHER | 1 | Jul 24, 2019 | clinicaltrials |
| NCT03136354 | Prospective Randomized Trial Comparing Endoscopic Submucosal Dissection Against Laparoscopic Assisted Gastrectomy for Treatment of Early Gastric Cancer(LGE) | completed | N/A | 36 | Chinese University of Hong KongOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT03780582 | Evaluation of Use of Diagnostic AI for Lung Cancer in Practice | unknown | N/A | 15 | Ensemble Group Holdings, LLCINDUSTRY | 1 | Jul 23, 2019 | clinicaltrials |
| NCT02281019 | SpyGlass AMEA Registry | completed | — | 526 | Boston Scientific CorporationINDUSTRY | 10 | Jul 10, 2019 | clinicaltrials |
| NCT03430752 | Comparing the Impact of Cancer on Quality of Life Between Survivors of Childhood Solid Tumors and Leukemia | completed | — | 135 | The University of Hong KongOTHER | 1 | Jun 28, 2019 | clinicaltrials |
| NCT00428220 | A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. | completed | N/A | 223 | PfizerINDUSTRY | 17 | Jun 27, 2019 | clinicaltrials |
| NCT01892345 | A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study) | terminated | Phase 3 | 143 | Alexion Pharmaceuticals, Inc.INDUSTRY | 18 | Jun 26, 2019 | clinicaltrials |
| NCT01271725 | LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures | completed | Phase 2 | 74 | Boehringer IngelheimINDUSTRY | 6 | Jun 17, 2019 | clinicaltrials |
| NCT00901901 | Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma(SEARCH) | completed | Phase 3 | 732 | BayerINDUSTRY | 26 | May 30, 2019 | clinicaltrials |
| NCT03631485 | Exploring the Mental Health of Parents Having Children With Cancer | completed | — | 181 | The University of Hong KongOTHER | 1 | May 30, 2019 | clinicaltrials |
| NCT03950102 | SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist | unknown | N/A | 40 | The University of Hong KongOTHER | 1 | May 28, 2019 | clinicaltrials |
| NCT02457039 | Acupuncture Prevents Chemobrain in Breast Cancer Patients | completed | N/A | 93 | The University of Hong KongOTHER | 2 | May 20, 2019 | clinicaltrials |
| NCT02186301 | TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy(EGFR) | terminated | Phase 2 / Phase 3 | 100 | Clovis Oncology, Inc.INDUSTRY | 7 | May 7, 2019 | clinicaltrials |
| NCT03021057 | Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas | unknown | Phase 2 | 33 | The University of Hong KongOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03240120 | A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism | unknown | Phase 3 | 99 | The University of Hong KongOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03647956 | Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors | unknown | Phase 2 | 40 | The University of Hong KongOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT01287741 | A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA) | terminated | Phase 3 | 1,418 | Hoffmann-La RocheINDUSTRY | 29 | Apr 12, 2019 | clinicaltrials |
| NCT01514110 | Gastric Cancer RAD001 Study | completed | Phase 1 / Phase 2 | 35 | Chinese University of Hong KongOTHER | 1 | Apr 2, 2019 | clinicaltrials |
| NCT01685138 | LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer | completed | Phase 2 | 124 | Novartis PharmaceuticalsINDUSTRY | 18 | Mar 26, 2019 | clinicaltrials |
| NCT03814369 | AmplifEYE Colonoscopy vs Standard Colonoscopy | completed | N/A | 355 | Queen Elizabeth Hospital, Hong KongOTHER | 1 | Mar 26, 2019 | clinicaltrials |
| NCT00096408 | Laparoscopic Approach to Cancer of the Endometrium | completed | Phase 3 | 760 | Queensland Centre for Gynaecological CancerOTHER_GOV | 4 | Mar 20, 2019 | clinicaltrials |
| NCT01210495 | Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma | completed | Phase 2 | 224 | PfizerINDUSTRY | 13 | Jan 9, 2019 | clinicaltrials |
| NCT03797755 | Prognosis of Patient Evaluated for Palliative Radiotherapy(PROPER) | unknown | — | 450 | Tuen Mun HospitalOTHER_GOV | 1 | Jan 9, 2019 | clinicaltrials |
| NCT00574873 | Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML | completed | Phase 3 | 502 | PfizerINDUSTRY | 29 | Jan 8, 2019 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials